Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to determine whether Guided Imagery and Progressive Muscle Relaxation techniques are effective in the management of pain, fatigue, nausea-vomit, anxiety and depression in patients with either prostate or breast cancer.
This study includes a total of 200 patients with prostate and breast cancer randomly assigned to either a control or intervention group.
The intervention group received in total 4 sessions of Guided Imagery (protocol floating on a cloud) and Progressive Muscle Relaxation (breathing exercises and use of 11 groups of muscle progressively tensing and relaxing).
Measurements included the assessment of pain, fatigue, nausea-vomit, depression, anxiety and quality of life. Additionally, saliva samples were collected prior and after the sessions as to assess saliva cortisol and saliva α-amylase.
The same measurements were received by the patients of the control group as to allow comparisons.
Condition | Intervention |
---|---|
Breast Cancer Prostate Cancer |
Other: Guided Imagery and Progressive Muscle Relaxation |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
Official Title: | A Randomized Clinical Trial on the Effect of Guided Imagery and Progressive Muscle Relaxation for the Management of Pain, Stress, Anxiety and Depression as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer |
- Stress [ Time Frame: 20 months ] [ Designated as safety issue: No ]Saliva α-amylase and saliva cortisol
- Quality of Life [ Time Frame: 20 months ] [ Designated as safety issue: No ]
- Fatigue [ Time Frame: 20 months ] [ Designated as safety issue: No ]
- Anxiety [ Time Frame: 20 months ] [ Designated as safety issue: No ]
- Depression [ Time Frame: 20 months ] [ Designated as safety issue: No ]
- Nausea-vomit [ Time Frame: 20 months ] [ Designated as safety issue: No ]
- Pain [ Time Frame: 20 months ] [ Designated as safety issue: No ]
Estimated Enrollment: | 200 |
Study Start Date: | April 2010 |
Study Completion Date: | October 2011 |
Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: Guided Imagery and Progressive Muscle Relaxation |
Other: Guided Imagery and Progressive Muscle Relaxation
4 supervised sessions per patient for 4 weeks additional to daily unsupervised sessions
|
Ages Eligible for Study: | 18 Years to 72 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Clinical diagnosis of breast or prostate cancer
- Must be able to follow instructions
- Good cognitive ability
- Willing to participate
Exclusion Criteria:
- Use of cortisone
- Xerostomia
- oral mucositis
Cyprus | |
Bank of Cyprus Oncology Centre | |
Nicosia, Cyprus, 2006 |
Principal Investigator: | Andreas I Charalambous, PhD | Cyprus University of Technology |
No publications provided
Responsible Party: | Dr. Andreas Charalambous, Lecturer-Researcher, Cyprus University of Technology |
ClinicalTrials.gov Identifier: | NCT01275872 History of Changes |
Other Study ID Numbers: | AC-GIPMR-85 |
Study First Received: | January 12, 2011 |
Last Updated: | October 31, 2011 |
Health Authority: | Cyprus: Cyprus National Bio-Ethics Committee |
Keywords provided by Cyprus University of Technology:
guided imagery progressive muscle relaxation complimentary and alternative medicine quality of life |
stress pain anxiety |
Additional relevant MeSH terms:
Breast Neoplasms Muscle Hypotonia Prostatic Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Neuromuscular Manifestations |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on October 18, 2012